ResearcherCedars-Sinai Medical CenterNo recent work listed
Michelle Guan
Matched on ORCID iD 0000-0003-3285-2120; OpenAlex author ID A5079514365. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2019: 2 papers · 2020: 2 papers · 2021: none · 2022: 1 paper
Papers 5
- Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. Co-author DOI 10.1016/j.pan.2021.09.015↗
- Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1177/1756284820964319↗
- Priority Rankings of Patient-Reported Outcomes for Pancreatic Ductal Adenocarcinoma: A Comparison of Patient and Physician Perspectives. Co-author DOI 10.6004/jnccn.2020.7548↗
- Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.humpath.2019.05.004↗
- Pancreatic cancer 'mismatch' in Lynch syndrome. Co-author DOI 10.1136/bmjgast-2019-000274↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew Eugene Hendifar · 5 shared papers, 2019–2022 · strength 0.62
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Paper Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal… DOI 10.1177/1756284820964319↗
- Paper Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarci… DOI 10.1016/j.humpath.2019.05.004↗
- Jun Gong · 4 shared papers, 2019–2022 · strength 0.50
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Paper Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal… DOI 10.1177/1756284820964319↗
- Paper Priority Rankings of Patient-Reported Outcomes for Pancreatic Ductal Adenocarcinoma: A Comparison of Patient and Physic… DOI 10.6004/jnccn.2020.7548↗
- Veronica Placencio-Hickok · 3 shared papers, 2020–2022 · strength 0.39
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Paper Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal… DOI 10.1177/1756284820964319↗
- Paper Priority Rankings of Patient-Reported Outcomes for Pancreatic Ductal Adenocarcinoma: A Comparison of Patient and Physic… DOI 10.6004/jnccn.2020.7548↗
- Brent K. Larson · 3 shared papers, 2019–2022 · strength 0.37
- Paper Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. DOI 10.1016/j.pan.2021.09.015↗
- Paper Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarci… DOI 10.1016/j.humpath.2019.05.004↗
- Paper Pancreatic cancer 'mismatch' in Lynch syndrome. DOI 10.1136/bmjgast-2019-000274↗
- Richard Tuli · 2 shared papers, 2019 · strength 0.23
- Simon K. Lo · 1 shared paper, 2022 · strength 0.14
- Natalie Moshayedi · 1 shared paper, 2022 · strength 0.14
- Nicholas N. Nissen · 1 shared paper, 2022 · strength 0.14
- Stephen Jacob Pandol · 1 shared paper, 2022 · strength 0.14
- Arsen Osipov · 1 shared paper, 2022 · strength 0.14
- Maria Q. B. Petzel · 1 shared paper, 2020 · strength 0.13
- Christopher E Forsmark · 1 shared paper, 2020 · strength 0.13
- Gillian K. Gresham · 1 shared paper, 2020 · strength 0.12
- Megan Philippa Hitchins · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.